Search
for
Sort by
Research 31–60 of 1000+
- The pathophysiology of polycystic ovary syndrome: trying to understand PCOS and its endocrinology
- Sex Hormone-Binding Globulin (SHBG) as an Early Biomarker and Therapeutic Target in Polycystic Ovary Syndrome
- The frequency of polycystic ovary syndrome in women with prediabetes compared with normoglycemic women
- Alopecia and Hirsuties
- Role of plasminogen activator inhibitor type 1 (PAI-1) in PCOS patient
- ACE2 and TMPRSS2 Potential Involvement in Genetic Susceptibility to SARS-COV-2 in Cancer Patients
- Androgen excess: a hallmark of polycystic ovary syndrome
- Efectos de la disminución de los depósitos tisulares de hierro sobre los factores de riesgo cardiovascular en pacientes con hiperandrogenismo ovárico funcional
- Polycystic ovary syndrome and insulin-resistant hyperinsulinemia
- A Case of Ovarian Hyperthecosis in a Postmenopausal Woman
- Identification and single-cell analysis of prognostic genes related to mitochondrial and neutrophil extracellular traps in bladder cancer
- Androgens and ovarian function: translation from basic discovery research to clinical impact
- Biomimetic Scaffolds—A Novel Approach to Three Dimensional Cell Culture Techniques for Potential Implementation in Tissue Engineering
- Cell Surface B2m-Free Human Leukocyte Antigen (HLA) Monomers and Dimers: Are They Neo-HLA Class and Proto-HLA?
- Causes and therapeutic limitations of clinical alopecia and the advent of human pluripotent stem cell follicular transplantation
- Therapeutic Efficacy and Promise of Human Umbilical Cord Mesenchymal Stem Cell-Derived Extracellular Vesicles in Aging and Age-Related Disorders
- Enter the Matrix: Fibroblast-immune cell interactions shape extracellular matrix deposition in health and disease.
- Paxillin regulates androgen receptor expression associated with granulosa cell focal adhesions
- Cytostatics and immunosuppressive drugs
- Fibroblast heterogeneity and tertiary lymphoid tissues in the kidney
- Management of Toxicities of Targeted Therapies
- The PDGF/PDGFR pathway as a drug target
- Lignans and Neolignans: Plant secondary metabolites as a reservoir of biologically active substances
- Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer
- Expression and roles of steroidogenic acute regulatory (StAR) protein in ‘non-classical’, extra-adrenal and extra-gonadal cells and tissues
- Polycystic Ovary Syndrome, Insulin Resistance, and Obesity: Navigating the Pathophysiologic Labyrinth
- Polycystic Ovary Syndrome and Oxidative Stress—From Bench to Bedside
- Spontaneous Lesions of Endangered Geriatric Julia Creek Dunnarts (Sminthopsis douglasi, Archer 1979) with Emphasis in Reproductive Pathology
- Physiopathology of polycystic ovary syndrome in endocrinology, metabolism and inflammation
- Targeting integrin pathways: mechanisms and advances in therapy